Home

Cannabinoids

Overview

Cannabis Industry Outline

Alzheimer's Disease

Cannabinoid Receptors

THC and CBD

Strategic Partnerships

Pain Relief

Medical Refractory Epilepsy

Eating Disorders

Dogs and Cats

Alzheimer's Disease

PRODUCTS

Investor Center

Overview

News & Filings

Team

Contact

Home

Cannabinoids

Overview

Cannabis Industry Outline

Alzheimer's Disease

Cannabinoid Receptors

THC and CBD

Strategic Partnerships

Pain Relief

Medical Refractory Epilepsy

Eating Disorders

Dogs and Cats

Alzheimer's Disease

PRODUCTS

Investor Center

Overview

News & Filings

Team

Contact

April 25, 2017

SEC Filing

Ram Mukunda

IGC Form 8-K

Ram Mukunda

April 25, 2017

SEC Filing

IGC Form 8-K

Ram Mukunda

April 25, 2017

SEC Filing

Source: /s/IGC-8-K-PR-NNW-Engagement-Apr-2517-AS-FILED.pdf

Newer PostIGC Appoints Medical Advisor Craig Cheifetz, M.D. to Consult on the Development of Cannabis- Based, Combination Therapies

Older PostIGC Engages NetworkNewsWire for Corporate Communications Solutions

Contact IGC

Contact Form

Name *

Name

First Name

Last Name

Email Address *

Subject *

Message *

Thank you! We will get back to you at your earliest convenience.

Email Address

Thank you for signing up!

IGC
PO BOX 60642
Potomac, Maryland
20859-0642 USA

T (301) 983 0998
F (240) 465 0273
E info@igcinc.us

India Globalization Capital, Potomac, United States301-983-0998